Mutant Huntingtin accumulation in the nucleus affects nucleolar function in Huntington's disease mouse models and patients at early stages

被引:0
|
作者
Soenmez, A. [1 ]
Spieth, S. [1 ,2 ]
Mustafa, R. [1 ,2 ]
Kojer, K. [3 ]
Litke, C. [2 ]
Kochi, J. [1 ]
Orth, M. [3 ]
Liss, B. [1 ]
Parlato, R. [1 ,2 ]
机构
[1] Ulm Univ, Inst Appl Physiol, Ulm, Germany
[2] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany
[3] Ulm Univ, Dept Neurol, Ulm, Germany
关键词
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
B 02-8
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin - A potential mechanism for loss of huntingtin function in Huntington's disease
    Busch, A
    Engemann, S
    Lurz, R
    Okazawa, H
    Lehrach, H
    Wanker, EE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 41452 - 41461
  • [22] Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
    Wang, Nan
    Gray, Michelle
    Lu, Xiao-Hong
    Cantle, Jeffrey P.
    Holley, Sandra M.
    Greiner, Erin
    Gu, Xiaofeng
    Shirasaki, Dyna
    Cepeda, Carlos
    Li, Yuqing
    Dong, Hongwei
    Levine, Michael S.
    Yang, X. William
    NATURE MEDICINE, 2014, 20 (05) : 540 - 545
  • [23] Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
    Nan Wang
    Michelle Gray
    Xiao-Hong Lu
    Jeffrey P Cantle
    Sandra M Holley
    Erin Greiner
    Xiaofeng Gu
    Dyna Shirasaki
    Carlos Cepeda
    Yuqing Li
    Hongwei Dong
    Michael S Levine
    X William Yang
    Nature Medicine, 2014, 20 : 536 - 541
  • [24] Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
    Graham, RK
    Slow, EJ
    Deng, Y
    Bissada, N
    Lu, G
    Pearson, J
    Shehadeh, J
    Leavitt, BR
    Raymond, LA
    Hayden, MR
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 444 - 455
  • [25] Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease
    Lu, Xiao-Hong
    Mattis, Virginia B.
    Wang, Nan
    Al-Ramahi, Ismael
    van den Berg, Nick
    Fratantoni, Silvina A.
    Waldvogel, Henry
    Greiner, Erin
    Osmand, Alex
    Elzein, Karla
    Xiao, Jingbo
    Dijkstra, Sipke
    de Pril, Remko
    Vinters, Harry V.
    Faull, Richard
    Signer, Ethan
    Kwak, Seung
    Marugan, Juan J.
    Botas, Juan
    Fischer, David F.
    Svendsen, Clive N.
    Munoz-Sanjuan, Ignacio
    Yang, X. William
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (268) : 268ra178
  • [26] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
    Karolina Pierzynowska
    Lidia Gaffke
    Zuzanna Cyske
    Grzegorz Węgrzyn
    Metabolic Brain Disease, 2019, 34 : 715 - 720
  • [27] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients
    Pierzynowska, Karolina
    Gaffke, Lidia
    Cyske, Zuzanna
    Wegrzyn, Grzegorz
    METABOLIC BRAIN DISEASE, 2019, 34 (03) : 715 - 720
  • [28] Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
    Wild, Edward J.
    Boggio, Roberto
    Langbehn, Douglas
    Robertson, Nicola
    Haider, Salman
    Miller, James R. C.
    Zetterberg, Henrik
    Leavitt, Blair R.
    Kuhn, Rainer
    Tabrizi, Sarah J.
    Macdonald, Douglas
    Weiss, Andreas
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (05): : 1979 - 1986
  • [29] Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington’s Disease
    Xiangqian Liu
    Ting Peng
    He Li
    Neuroscience Bulletin, 2018, 34 : 870 - 872
  • [30] Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington's Disease
    Xiangqian Liu
    Ting Peng
    He Li
    Neuroscience Bulletin, 2018, (05) : 870 - 872